Synartro AB
556866-4220ActiveDeveloping sustained local injection treatments for osteoarthritis pain relief.
Översikt
- 1–4
- Anställda
- ≤1t SEK
- Omsättning
- 2011
- Grundat
Nyckelbeslutsfattare
Magnus Hurst
CFO & acting CEO
Antonio Bermejo Gómez
Chief Development Officer
Mats Persson
Board Member
Maria Nyhage
Board Member
+2 fler kontakter i Funnelfeedr
Beskrivning
Synartro AB is a clinical stage Swedish life science company focused on developing novel local injection treatments for osteoarthritis (OA). Their core innovation lies in a patented technology that chemically binds existing, proven drugs to a base compound. This process enables sustained drug releas...
Taggar
Nyckelord
Företagsinformation
- Bransch
- Annan naturvetenskaplig och teknisk forskning och utveckling
- Juridisk form
- Aktiebolag
- Momsnummer
- SE556866422001
Beslutsfattare
6 kontakter i FunnelfeedrMagnus Hurst
CFO & acting CEO
Antonio Bermejo Gómez
Chief Development Officer
Mats Persson
Board Member
Maria Nyhage
Board Member
Fredrik Lehmann
Founder & Chairman
Övriga kontakter
Dr. Ali Mobasheri
Scientific Advisor
Liknande företag
20 liknande företag i FunnelfeedrStayble Therapeutics AB
5–9 anställdaDeveloping an injection treatment for pain caused by disc herniation.
Pharmnovo Aktiebolag
1–4 anställdaDeveloping non-addictive delta opioid receptor agonists for neuropathic pain.
Xintela AB
10–19 anställdaDeveloping stem cell and targeted cancer therapies for unmet needs.
REGENARTI AS
Norwegian company developing peptide-enhanced gel for joint repair.
SynAct Pharma AB
5–9 anställdaClinical-stage biotech resolving inflammation via novel oral therapies.
Utforska mer
Frågor om Synartro AB
Vill du se Funnelfeedr i praktiken?
Boka en gratis demo och upptäck hur Funnelfeedr hjälper dig att hitta och konvertera dina idealkunder.
Boka en demo